SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-21-000017
Filing Date
2021-08-06
Accepted
2021-08-06 08:31:19
Documents
78
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q anip-20210630x10q.htm   iXBRL 10-Q 2433967
2 EX-31.1 anip-20210630ex311983e65.htm EX-31.1 11359
3 EX-31.2 anip-20210630ex312137405.htm EX-31.2 10779
4 EX-32.1 anip-20210630ex3213a04f1.htm EX-32.1 8607
  Complete submission text file 0001023024-21-000017.txt   9062950

Data Files

Seq Description Document Type Size
5 EX-101.SCH anip-20210630.xsd EX-101.SCH 48636
6 EX-101.CAL anip-20210630_cal.xml EX-101.CAL 65838
7 EX-101.DEF anip-20210630_def.xml EX-101.DEF 210753
8 EX-101.LAB anip-20210630_lab.xml EX-101.LAB 391788
9 EX-101.PRE anip-20210630_pre.xml EX-101.PRE 389099
10 EXTRACTED XBRL INSTANCE DOCUMENT anip-20210630x10q_htm.xml XML 1846860
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 211150920
SIC: 2834 Pharmaceutical Preparations